PMA device
Senza Spinal Cord Stimulation (SCS) System
Nevro Corporation · Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW, Class III) · First FDA decision Apr 15, 2016, newest May 27, 2025Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
19
PMA pathway
Device trials
10
Naming "Senza"
MAUDE reports
6,572
Brand "Senza", since 2015
PubMed studies
54
Mentioning "Senza"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Senza Spinal Cord Stimulation (SCS) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 19 decisions filed under this name.
- Senza Spinal Cord Stimulation (SCS) SystemPMA supplement
P130022-S066 · Decided May 27, 2025 · 186 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
P130022-S058 · Decided Sep 24, 2024 · 180 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
- Senza Spinal Cord Stimulation (SCS) SystemsPMA supplement
P130022-S050 · Decided Nov 1, 2024 · 536 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
3 more FDA decisions with a free account
Older decisions: P130022-S039, P130022-S037, P130022-S036, P130022-S034, P130022-S028, P130022-S024, P130022-S022, P130022-S021, P130022-S019, P130022-S017, P130022-S014, P130022-S010, P130022-S004
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Senza", any status and sponsor, newest update first.
- Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb PainPivotal-lookingCompleted
Nevro CorpNot on our public-company list
NCT03228420 · 430 participants · Start Jul 20, 2017 · Primary completion May 1, 2020
Device: Senza HF10 Therapy · For: Painful Diabetic Neuropathy
Sites: Bradenton, Florida; Stockbridge, Georgia; Durham, North Carolina · 4 sites in all
- Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back PainPivotal-lookingCompleted
Nevro CorpNot on our public-company list
NCT03680846 · 211 participants · Start Sep 5, 2018 · Primary completion Oct 6, 2020
Device: HF10 Therapy · For: Back Pain
Sites: Redwood City, California
- Comparing Long-term Effectiveness of High Frequency and Burst Spinal Cord StimulationActive, not recruiting
Stanford UniversityAcademic, hospital or other
NCT03681262 · 7 participants · Start Aug 1, 2019 · Primary completion Dec 31, 2023
Device: High frequency spinal cord stimulation; Burst spinal cord stimulation · For: Chronic Pain
Sites: Redwood City, California
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Senza", and for the whole product code for context.
This brand
6,572 reports: 219 malfunction, 5,379 injury, 972 death
Whole product code LGW
301,867 reports: 79,174 malfunction, 220,939 injury, 1,642 death
Newest reports for this brand
- SenzaInjury
3008514029-2026-00510 · Received Oct 28, 2026 · Event dated Oct 8, 2026
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Wound Dehiscence; Unspecified Infection; Insufficient Information
- SenzaInjury
3008514029-2026-00511 · Received Oct 28, 2026 · Event dated Oct 8, 2026
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Seroma
- SenzaInjury
3008514029-2026-00512 · Received Oct 28, 2026 · Event dated Dec 31, 2025
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection; Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Senza"[tiab]. The summary above synthesizes these.
- Stimulating Results Signal a New Treatment Option for People Living With Painful Diabetic Neuropathy.
Armstrong DG, Grunberger G · J Diabetes Sci Technol · 2023Review, Research Support, U.S. Gov't, Non-P.H.S.
- [Not Available].
Cimino G · Physis Riv Int Stor Sci · 2015Historical Article
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial.
Petersen EA, Stauss TG, Scowcroft JA, et al. · JAMA Neurol · 2021Multicenter Study, Randomized Controlled Trial
- LETTERA DEL DIRETTORE.
Ann Ital Chir · 2020Letter
- Spinal cord stimulation in painful diabetic neuropathy: An overview.
Petersen EA · Diabetes Res Clin Pract · 2023Review
- Treatment of Painful Diabetic Neuropathy with 10 kHz Spinal Cord Stimulation: Long-Term Improvements in Hemoglobin A1c, Weight, and Sleep Accompany Pain Relief for People with Type 2 Diabetes.
Klonoff DC, Levy BL, Jaasma MJ, et al. · J Pain Res · 2024
- Che farò senza polifenoli?
Haslam E · Basic Life Sci · 1999Review
- A single-center real-world review of 10 kHz high-frequency spinal cord stimulation outcomes for treatment of chronic pain.
Ehsanian R, Wu V, Grandhe R, et al. · Interv Pain Med · 2024
- Improved Sensation Resulting From Spinal Cord Stimulation for the Treatment of Painful Diabetic Neuropathy: The Possible Role of Stochastic Resonance.
Schnapp WD, Delcroix GJ · Pain Physician · 2022Randomized Controlled Trial, Multicenter Study
- High-frequency 10ߙkHz Spinal Cord Stimulation for Chronic Back and Leg Pain: Cost-consequence and Cost-effectiveness Analyses.
Taylor RS, Bentley A, Campbell B, et al. · Clin J Pain · 2020Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Health care resource utilization and costs in patients with painful diabetic neuropathy treated with 10 kHz spinal cord stimulation therapy.
Taylor RS, Lad SP, White JL, et al. · J Manag Care Spec Pharm · 2023Randomized Controlled Trial
- Long-term efficacy of 10ߙkHz spinal cord stimulation in managing painful diabetic neuropathy: A post-study survey.
Petersen EA, Sills SM, Stauss TG, et al. · Pain Pract · 2025Randomized Controlled Trial
Other devices of this type
Also filed under product code LGW.
- Precision Spinal Cord Stimulator (SCS) SystemsBoston Scientific Corp · PMA 2026
- Saluda Medical Evoke SCS SystemSaluda Medical Pty, Ltd. · PMA 2026
- Master RestoreMedtronic Neuromodulation · PMA 2026
- RestoreMedtronic Neuromodulation · PMA 2025
- Genesis and Eon Family Neurostimulation (Ipg) SystemsAbbott Medical · PMA 2016
- Genesis Neurostimulation SystemAbbott Medical · PMA 2024
- Precision Spectra Spinal Cord Stimulator (SCS) SystemBoston Scientific Corp · PMA 2021
- Proclaim family of SCS IPGsAbbott Medical · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.